Oklahoma Senate Bill SB1483

Oklahoma 2026 Regular Session

• Introduced: 2/2/26
• Refer: 2/3/26

Caption

Civil liability; making vaccine manufacturer liable under certain conditions; directing certain relief. Effective date.

Summary

SB 1483 creates a new civil liability cause of action against vaccine manufacturers in Oklahoma. The bill defines “advertise” broadly to include television, radio, print, internet, digital media, product placement, influencer promotions, and other paid promotional activity, while excluding ordinary communications between health care providers and patients and promotional materials displayed in clinical settings. Under the bill, a manufacturer becomes liable to an individual if it advertises a vaccine in Oklahoma and the advertised vaccine causes harm or injury to that individual. The measure also sets a three-year statute of limitations for bringing an action under the new section, measured from when the cause of action accrues. If a claimant prevails, the court must award actual damages, court costs, and reasonable attorney fees. The bill would be codified in Title 76 of the Oklahoma Statutes and would take effect November 1, 2026.

Impact

SB 1483 would add a new statutory basis for product-related civil claims specifically targeting vaccine manufacturers, creating liability exposure tied to advertising activity in Oklahoma. It would affect vaccine manufacturers, injured individuals, health care providers indirectly through the bill’s advertising exclusions, and courts handling these claims. The bill would also establish a specific limitations period and mandatory fee-shifting and damages provisions for successful plaintiffs.

Sentiment

Based on the available context, the bill appears to have been introduced and referred to the Senate Health and Human Services committee without recorded votes or committee debate in the provided materials. As a result, there is no documented floor or committee sentiment in the record supplied here. The bill’s framing suggests a consumer-protection or accountability approach, but the absence of discussion transcripts means the level of support or opposition cannot be directly measured from the available history.

Contention

The main point of contention is likely the bill’s imposition of liability on vaccine manufacturers for harm allegedly caused by an advertised vaccine, which could be viewed as expanding tort exposure in a highly regulated public-health area. Supporters may see it as a way to hold manufacturers accountable for promotional claims, while opponents may argue it could discourage vaccine promotion, increase litigation, and conflict with existing vaccine liability frameworks. The bill’s broad definition of advertising and its exclusion for provider-patient communications may also be scrutinized for how it distinguishes marketing from clinical counseling.